Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

被引:111
|
作者
Zou, Peng [1 ,2 ]
Xia, Yiqun [3 ]
Ji, Jiansong [4 ]
Chen, Weiqian [1 ,4 ]
Zhang, Jinsan [1 ]
Chen, Xi [1 ]
Rajamanickam, Vinothkumar [1 ]
Chen, Gaozhi [1 ]
Wang, Zhe [1 ]
Chen, Lingfeng [1 ]
Wang, Yifeng [1 ]
Yang, Shulin [2 ]
Liang, Guang [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China
[2] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Digest Dis, Wenzhou 325035, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Lishui 323000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Thioredoxin reductase 1; Reactive oxygen species; Piperlongumine; ER stress; Mitochondrial dysfunction; THIOREDOXIN REDUCTASE 1; REACTIVE OXYGEN; CELL-DEATH; APOPTOSIS; STRESS; ACTIVATION; RESISTANCE; TRASTUZUMAB; GLUTATHIONE; MECHANISMS;
D O I
10.1016/j.canlet.2016.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Piperlongumine (PL), a natural alkaloid isolated from the fruit of long pepper, is known to selectively kill tumor cells while sparing their normal counterparts. However, the cellular target and potent anticancer efficacy of PL in numerous types of human cancer cells have not been fully defined. We report here that PL may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec) containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells. By inhibiting TrxR1 activity and increasing intracellular ROS levels, PL induces a lethal endoplasmic reticulum stress and mitochondrial dysfunction in human gastric cancer cells. Importantly, knockdown of TrxR1 sensitizes cells to PL treatment, and PL displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells. In vivo, PL treatment markedly reduces the TrxR1 activity and tumor cell burden. Remarkably, TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues. Targeting TrxR1 with PL thus discloses a previously unrecognized mechanism underlying the biological activity of PL and provides an in-depth insight into the action of PL in the treatment of gastric cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 50 条
  • [21] A Novel TrxR1 Inhibitor Regulates NK and CD8+T Cell Infiltration and Cytotoxicity, Enhancing the Efficacy of Anti-PD-1 Immunotherapy against Hepatocarcinoma
    Su, Xiaoxia
    Yin, Hanwei
    Bai, Man
    Liu, Jiayi
    Liu, Runyu
    Zeng, Huihui
    Wen, Jinhua
    JOURNAL OF IMMUNOLOGY, 2023, 210 (05): : 681 - 695
  • [22] RETRACTED: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer (Retracted article. See vol. 41, 2022)
    Zhang, Haiyong
    Wu, Jing
    Yuan, Jinqiu
    Li, Huafu
    Zhang, Yawei
    Wu, Wang
    Chen, Wei
    Wang, Chunming
    Meng, Sijun
    Chen, Songyao
    Huo, Mingyu
    He, Yulong
    Zhang, Changhua
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [23] The Au clusters induce tumor cell apoptosis via specifically targeting thioredoxin reductase 1 (TrxR1) and suppressing its activity
    Liu, Ru
    Wang, Yaling
    Yuan, Qing
    An, Deyi
    Li, Jingyuan
    Gao, Xueyun
    CHEMICAL COMMUNICATIONS, 2014, 50 (73) : 10687 - 10690
  • [24] A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery
    Alessio Metere
    Francesca Frezzotti
    Claire Elizabeth Graves
    Massimo Vergine
    Alessandro De Luca
    Donatella Pietraforte
    Laura Giacomelli
    Cancer Cell International, 18
  • [25] Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells
    Sang, Jun
    Liu, Chen-Kai
    Liu, Jue
    Luo, Guan-Cong
    Zheng, Wei-Ji
    Bai, Ya
    Jiang, De-Yun
    Pu, Jiang-Ni
    An, Su
    Xu, Tian-Rui
    BIOCHEMICAL PHARMACOLOGY, 2024, 223
  • [26] The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
    Chen, Gong
    Chen, Qiong
    Zeng, Fanxu
    Zeng, Liang
    Yang, Haiyan
    Xiong, Yi
    Zhou, Chunhua
    Liu, Li
    Jiang, Wenjuan
    Yang, Nong
    Zhang, Yongchang
    ONCOTARGET, 2017, 8 (70) : 115270 - 115279
  • [27] Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS
    Zhang, Tingting
    Zheng, Peisen
    Shen, Xin
    Shao, Rongrong
    Wang, Bin
    Shen, Huanpei
    Zhang, Jingjing
    Xia, Yiqun
    Zou, Peng
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 141 : 93 - 102
  • [28] Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells
    Chen, Xi
    Chen, Xiaoming
    Zhang, Xi
    Wang, Li
    Cao, Peihai
    Rajamanickam, Vinothkumar
    Wu, Chao
    Zhou, Huiping
    Cai, Yuepiao
    Liang, Guang
    Wang, Yi
    REDOX BIOLOGY, 2019, 21
  • [29] A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery
    Metere, Alessio
    Frezzotti, Francesca
    Graves, Claire Elizabeth
    Vergine, Massimo
    De Luca, Alessandro
    Pietraforte, Donatella
    Giacomelli, Laura
    CANCER CELL INTERNATIONAL, 2018, 18
  • [30] Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a
    Rajamanickam, Vinothkumar
    Yan, Tao
    Wu, Liangrong
    Zhao, Yanni
    Xu, Xiaohong
    Zhu, Heping
    Chen, Xi
    Wang, Meihong
    Liu, Zhoudi
    Liu, Zhiguo
    Liang, Guang
    Wang, Yi
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 247 - 263